All EHA CAR-T Abstracts
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
Non-specific
Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin’s Lymphoma (NHL)
This study evaluated the impact of prior lines of therapy on the efficacy of CAR-T and ASCT and found that OS was significantly longer, with a trend toward longer PFS, […]
CAR-T Therapy for Lymphoma with Prophylactic Tocilizumab: Decreased Rates of Severe Cytokine Release Syndrome without Excessive Neurologic Toxicity
Cytokine release syndrome is a well known complication of CAR-T therapy that can be treated with tocilizumab. This poster presents outcomes for patients treated with locally manufactured antiCD19 CAR-T cells […]